DAIC

FEBRUARY 10, 2025

tim.hodson Mon, 02/10/2025 - 12:43 Feb. 6, 2025 Eko Health, a leader in applying artificial intelligence (AI) for the early detection of heart and lung diseases, recently announcedpublication of a peer-reviewed study evaluating its novel algorithm for the detection of pulmonary hypertension (PH).

Research 64

Research Innovation Pulmonary Hypertension 64

DAIC

FEBRUARY 14, 2025

tim.hodson Fri, 02/14/2025 - 14:32 Feb. tim.hodson Fri, 02/14/2025 - 14:32 Feb. The presentation,"Effects of Atrioventricular Interval Modulation (AVIM) Therapy in Subjects with Hypertension and Diastolic Dysfunction,"was deliveredby Marat Fudim, M.D., Advanced Heart Failure Cardiologist, Duke Health on Feb.

Blood Pressure 52

Blood Pressure Heart Failure Hypertension Technology 52

DAIC

JANUARY 8, 2025

tim.hodson Wed, 01/08/2025 - 14:11 Jan. 8, 2025 Mineralys Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension, chronic kidney disease (CKD) and other diseases, hasannounced that the U.S. The Company anticipates initiating the trial in the first quarter of 2025.

Blood Pressure 52

Blood Pressure Hypertension Kidney Disease BMI 52

Hypertension Journal

MARCH 18, 2025

Hypertension, Volume 82, Issue 4 , Page 611-614, April 1, 2025.

Hypertension 40

Hypertension 40

DAIC

MARCH 26, 2025

tim.hodson Wed, 03/26/2025 - 14:25 March 17, 2025 Bayer recently announcedthat the U.S. 2 Most are balancing multiple comorbidities, such as obesity, diabetes, hypertension and chronic kidney disease (CKD). Accessed February 21, 2025. Accessed March 5, 2025. Accessed February 21, 2025. 4 Approximately 6.7

Heart Failure 52

Heart Failure Preserved Ejection Fraction Kidney Disease ACE Inhibitor 52

Hypertension Journal

MARCH 18, 2025

Hypertension, Volume 82, Issue 4 , Page 543-548, April 1, 2025.

Hypertension 40

Hypertension 40

Hypertension Journal

JANUARY 14, 2025

Hypertension, Volume 82, Issue 2 , Page 161-165, February 1, 2025.

Blood Pressure 75

Blood Pressure Hypertension 75

Hypertension Journal

MARCH 18, 2025

Hypertension, Volume 82, Issue 4 , Page 624-626, April 1, 2025.

Hypertension 40

Hypertension 40

Hypertension Journal

MARCH 18, 2025

Hypertension, Volume 82, Issue 4 , Page 598-600, April 1, 2025.

Hypertension 40

Hypertension Pulmonary 40

Hypertension Journal

NOVEMBER 11, 2024

Hypertension, Volume 82, Issue 1 , Page 3-7, January 1, 2025.

Hypertension 40

Hypertension 40

Hypertension Journal

FEBRUARY 18, 2025

Hypertension, Volume 82, Issue 3 , Page 460-462, March 1, 2025.

Hypertension 40

Hypertension Pulmonary 40

Hypertension Journal

JANUARY 14, 2025

Hypertension, Volume 82, Issue 2 , Page e5-e5, February 1, 2025.

Hypertension 40

Hypertension 40

Hypertension Journal

FEBRUARY 18, 2025

Hypertension, Volume 82, Issue 3 , Page 407-410, March 1, 2025.

Hypertension 40

Hypertension 40

Hypertension Journal

FEBRUARY 18, 2025

Hypertension, Volume 82, Issue 3 , Page 403-406, March 1, 2025.

Hypertension 40

Hypertension Stenosis 40

DAIC

JANUARY 14, 2025

Photo: American Heart Association tim.hodson Tue, 01/14/2025 - 16:05 Jan. 9, 2025 Gender-based racism through microaggressions may be linked to higher blood pressure postpartum and beyond, according to new research published in Hypertension , a peer-reviewed journal of the American Heart Association. Cameron, M.D,

Blood Pressure 52

Blood Pressure Research Hypertension Public Health 52

Hypertension Journal

FEBRUARY 18, 2025

Hypertension, Volume 82, Issue 3 , Page e22-e24, March 1, 2025.

Hypertension 40

Hypertension 40

Hypertension Journal

DECEMBER 17, 2024

Hypertension, Volume 82, Issue 1 , Page 69-71, January 1, 2025.

Hypertension 40

Hypertension 40

Hypertension Journal

FEBRUARY 18, 2025

Hypertension, Volume 82, Issue 3 , Page e25-e27, March 1, 2025.

Hypertension 40

Hypertension 40

Hypertension Journal

FEBRUARY 18, 2025

Hypertension, Volume 82, Issue 3 , Page e28-e30, March 1, 2025.

Hypertension 40

Hypertension 40

Hypertension Journal

FEBRUARY 18, 2025

Hypertension, Volume 82, Issue 3 , Page e31-e33, March 1, 2025.

Hypertension 40

Hypertension 40

Circulation

MARCH 30, 2025

Circulation, Volume 151, Issue 13 , Page e866-e866, April 1, 2025.

Hypertension 45

Hypertension Circulation 45

Hypertension Journal

NOVEMBER 6, 2024

Hypertension, Volume 82, Issue 1 , Page 72-83, January 1, 2025. BACKGROUND:Hypertension increases the risk of lymphedema in patients with comorbidities, but whether hypertension directly compromises lymph vessel (LV) function and lymph flow is unclear. Mesenteric lymph flow in vivo was 2.9-fold

Hypertension 40

Hypertension Pharmacology 40

HCPLive

NOVEMBER 18, 2024

In these updates and new sections, the 2025 GOLD report included highlighted climate change, cardiovascular risk, and pulmonary hypertension.

Pulmonary 64

Pulmonary Hypertension 64

Hypertension Journal

NOVEMBER 13, 2024

Hypertension, Volume 82, Issue 1 , Page 14-25, January 1, 2025. Podocyte dysfunction, resulting from oxidative stress, dysregulated prosurvival signaling, or structural damage, can drive the development of proteinuria and glomerulosclerosis in hypertensive nephropathy.

Hypertension 40

Hypertension Kidney Disease Research 40

DAIC

FEBRUARY 18, 2025

tim.hodson Tue, 02/18/2025 - 10:08 Feb. 13, 2025 Research from Cedars-Sinai investigators and collaborators at other leading medical institutions is helping to provide more treatment options to people living with tricuspid valve disease. Image by Getty.

Tricuspid 52

Tricuspid Open-Heart Surgery Quality of Life Anatomy 52

Hypertension Journal

JULY 16, 2024

Hypertension, Volume 82, Issue 1 , Page 26-35, January 1, 2025. Hypertension management involves using blood pressure and other biometric data from connected devices and generative AI to communicate with patients and health care professionals.

Hypertension 40

Hypertension Blood Pressure Technology 40

Circulation

MARCH 9, 2025

Circulation, Volume 151, Issue 10 , Page 716-732, March 11, 2025. Albuminuriaincreased urine albumin excretionis associated with cardiovascular mortality among patients with diabetes, hypertension, chronic kidney disease, or heart failure, as well as among adults with few cardiovascular risk factors.

Kidney Disease 83

Kidney Disease Biomarkers Heart Failure Risk Factors 83

DAIC

NOVEMBER 8, 2024

It becomes effective January 1, 2025, and is expected to remain effective for up to three years. This is a major step forward in the reimbursement available for the Paradise uRDN system, creating additional financial support for hospitals and physicians to provide this novel and effective therapy to their uncontrolled hypertension patients.”

CMS 40

CMS Ultrasound Blood Pressure Reimbursement 40

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page ATP282-ATP282, February 1, 2025. The main risk factor is hypertension, and blood pressure (BP) control is crucial in the primary and secondary prevention of stroke. The 2020 AHA Guideline was used to define hypertension and target BP. Statistical analysis was performed using STATA/SE 17.0

Hypertension 40

Hypertension Strokes Stroke Blood Pressure 40

Stroke Journal

DECEMBER 9, 2024

Stroke, Volume 56, Issue 1 , Page 105-112, January 1, 2025. BACKGROUND:The focus for reducing hypertension-related cardiovascular disease is the management of blood pressure. Participants were stratified by duration of recognized hypertension: normotensive (0 years), 5 years, 6 to 20 years, or 21+ years.

Hypertension 40

Hypertension Strokes Stroke Blood Pressure 40

Dr. Paddy Barrett

JANUARY 31, 2025

📅 Date: Wednesday, February 5th 2025 ⏰ Time: 2 pm Irish Time 📍 Where: Online (Link provided after registration) 👉 Click here to reserve your spot now. Sign Me Up 1 The global epidemiology of hypertension. 5 Role of insulin resistance in essential hypertension. The Cholesterol Secrets Masterclass?

Blood Pressure 79

Blood Pressure Heart attacks Heart Attack Cholesterol 79

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page ADP50-ADP50, February 1, 2025. million patients with hypertension were assessed. However, patients on non-ACEI/ARBs anti-hypertensive medications had a similar risk of SAH risk compared to those not on any antihypertensives [HR:1.00(0.97-1.04), million,follow-up:6.3 years, average age 61.9,

Hemorrhage 40

Hemorrhage Hypertension Aneurysm Pharmacology 40

Circulation

FEBRUARY 16, 2025

Circulation, Volume 151, Issue 7 , Page 508-510, February 18, 2025.

Diabetes 45

Diabetes Hypertension Circulation 45

Circulation

MARCH 9, 2025

Circulation, Volume 151, Issue 10 , Page e686-e686, March 11, 2025.

Preserved Ejection Fraction 45

Preserved Ejection Fraction Article Heart Failure Pulmonary 45

Hypertension Journal

JANUARY 14, 2025

Hypertension, Volume 82, Issue 2 , Page e4-e4, February 1, 2025.

Circulation 45

Circulation Hypertension 45

Hypertension Journal

MARCH 18, 2025

Hypertension, Volume 82, Issue 4 , Page 638-639, April 1, 2025.

Blood Pressure 40

Blood Pressure Hypertension 40

Circulation

MARCH 16, 2025

Circulation, Volume 151, Issue 11 , Page e763-e763, March 18, 2025.

Preserved Ejection Fraction 45

Preserved Ejection Fraction Heart Failure Pulmonary Hypertension 45